Form 4: TD SYNNEX Corp: Director Sells Shares Under 10b5-1 Plan

TD SYNNEX Corp. Director Dennis Polk executed a Rule 10b5-1 trading plan, resulting in the sale of common stock valued at approximately $283.8 to $285.07 per share.

Summary

• Director Dennis Polk sold TD SYNNEX Corp. common stock on June 15, 2026, through a pre-established Rule 10b5-1 trading plan.
• The sales were conducted on behalf of the Polk Family Trust, of which Mr. Polk is a trustee.
• Transactions involved weighted average sales prices ranging from $283.64 to $283.97 for some sales, and $284.01 to $284.99 for others.
• The filing details the acquisition and disposition of non-derivative securities, with specific amounts and prices noted.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to the significant sale of shares by a director, despite being executed under a Rule 10b5-1 plan.

Negatives

• Director Dennis Polk sold a significant number of TD SYNNEX Corp. shares.
• The sales were executed under a pre-planned trading strategy, indicating a predetermined intent to sell.

Risks

• The sale of shares by a director, even under a 10b5-1 plan, could be interpreted by the market as a lack of confidence in future stock performance.
• The Rule 10b5-1 plan was adopted on January 16, 2026, suggesting a planned divestment over a period.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on past transactions.

Management Comments

• The sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 16, 2026, on behalf of the Polk Family Trust of which the reporting person is a trustee.
• Represents the weighted average sales price for a number of transactions effected at prices ranging from $283.64 to $283.97.
• Represents the weighted average sales price for a number of transactions effected at prices ranging from $284.01 to $284.99.

Industry Context

StockSavvy.ai notes that insider sales, even those executed under Rule 10b5-1 plans, are closely watched by the market. While these plans are designed to avoid accusations of insider trading by establishing a predetermined selling schedule, significant sales by directors can still influence investor sentiment and stock price.

Stakeholder Impact

• Shareholders may view the director's sale of stock negatively, potentially impacting share price due to perceived lack of confidence.
• The Polk Family Trust, as a beneficiary of the sales, will see an increase in liquid assets.

Key Dates

Recommendation

While the sale by a director is a negative signal, it was conducted under a pre-established Rule 10b5-1 plan, mitigating concerns of opportunistic insider trading. The filing itself does not provide enough information to warrant a strong buy or sell recommendation, suggesting a 'hold' position to observe further developments.

Keywords

TD SYNNEX Corp, SNX, Form 4, Insider Trading, Rule 10b5-1, Stock Sale, Director Transaction, Beneficial Ownership, Polk Family Trust